Gufic Biosciences bulk deals, insider trading and stake changes
NSE: GUFICBIOBSE: 509079Pharmaceuticals & BiotechnologySmall Cap
Gufic Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1985 on BSE, Oct 2004 on NSE
Last close ₹418.80down ₹4.95 (1.17%)BSE ₹420.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹423.75.
29 Oct: open ₹423.00, high ₹424.05, low ₹416.25
52-week range of traded prices to 29 Oct 2026
₹268.00Low, 9 Mar 2026₹467.80High, 7 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,200 Cr959th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 57.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 26,73756.8% delivered
Gufic Biosciences' insiders have 9 trade disclosures on record, the latest on 17 Jul 2023. Its promoter group made no purchase or sale on the market in the 12 months to 29 Oct 2026.
Gufic Biosciences insider trading
The company's own latest disclosure on record is from Jun 2022.Insider trading, all companies
Jul 2023
- DILIP GHOSH₹0.35 Cr15,000 sharesPledge · Designated Person · 12 Jul 2023 · disclosed 17 Jul
Jun 2022
- JAYESH PANNALAL CHOKSI₹10 Cr4,68,000 sharesSold or invoked · Promoter And Designated Person · 2 Jun 2022 · disclosed 23 Aug
- JAYESH CHOKSI₹9.79 Cr4,50,000 sharesSold · Promoters · 2 Jun 2022 · disclosed 3 Jun · stake 25.95% before, 25.49% after
- JAYESH CHOKSI₹0.40 Cr18,000 sharesSold · Promoters · 2 Jun 2022 · disclosed 3 Jun · stake 25.49% before, 25.47% after
Jun 2021
- Mr. Jayesh P.Choksi₹0.71 Cr71,48,570 sharesReceived · Promoters · 7 Jun 2021 · disclosed 8 Jun · Scheme of Amalgamation/Merger/Demerger/Arrangement · held 1,80,10,259 before, holds 2,51,58,829 after
- Gufic Private Limited₹0.48 Cr48,17,366 sharesReceived · Promoters · 7 Jun 2021 · disclosed 8 Jun · Scheme of Amalgamation/Merger/Demerger/Arrangement · held 53,74,157 before, holds 1,01,91,523 after
- Mrs. Vipula J. Choksi₹0.71 Cr71,48,570 sharesReceived · Immediate relative · 7 Jun 2021 · disclosed 8 Jun · Scheme of Amalgamation/Merger/Demerger/Arrangement · held 28,85,273 before, holds 1,00,33,843 after
- Mr. Pranav J. Choksi0sharesGave · Promoters · 7 Jun 2021 · disclosed 8 Jun · Scheme of Amalgamation/Merger/Demerger/Arrangement · held 72,68,626 before, holds 72,68,626 after
- Zircon Teconica Private Limited (Formerly known as Zircon Finance and Leasing Private Limited)0sharesGave · Promoters · 7 Jun 2021 · disclosed 8 Jun · Scheme of Amalgamation/Merger/Demerger/Arrangement · held 2,05,23,330 before, holds 2,05,23,330 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Gufic Biosciences stake sales and purchases
All 17 disclosures on record.
Jun 2022
- SoldMr. Jayesh P Choksi · promoter0.48% of the company4,68,000 sharesholds 25.47% after2 Jun 2022 · filed under the 2% rule · Open market
Jun 2021
- AcquiredMr. Jayesh P. Choksi · promoter7.37% of the company71,48,570 sharesholds 25.95% after7 Jun 2021 · filed under the 2% rule
- AcquiredGufic Private Limited · promoter4.97% of the company48,17,366 sharesholds 10.51% after7 Jun 2021 · filed under the 2% rule
- AcquiredMr. Pranav J. Choksi · promoterholds 7.50% after7 Jun 2021 · filed under the 2% rule
- AcquiredMrs. Vipul J. Choksi · promoter7.37% of the company71,48,570 sharesholds 10.35% after7 Jun 2021 · filed under the 2% rule
- AcquiredZircon Teconica Private Limited · promoterholds 21.17% after7 Jun 2021 · filed under the 2% rule
- AcquiredMrs. Vipula J Choksi7.37% of the company71,48,570 sharesholds 10.35% after7 Jun 2021 · filed under the 5% rule
- AcquiredMr Pranav J Choksi · promoterholds 7.50% after4 Jun 2021 · filed under the 2% rule
- AcquiredZircon Teconica Private Limited · promoterholds 21.17% after4 Jun 2021 · filed under the 2% rule
- AcquiredMr Jayesh P Choksi · promoter7.37% of the company71,48,570 sharesholds 25.95% after4 Jun 2021 · filed under the 2% rule
- AcquiredMrs Vipula Choksi · promoter7.37% of the company71,48,570 sharesholds 10.35% after4 Jun 2021 · filed under the 2% rule
- AcquiredM/s Gufic Private Limited · promoter4.97% of the company48,17,366 sharesholds 10.51% after4 Jun 2021 · filed under the 2% rule
- AcquiredMr Jayesh P Chokshi · promoter7.37% of the company71,48,570 sharesholds 25.95% after4 Jun 2021 · filed under the 2% rule
May 2021
- SoldSBI Mutual Fund under its various schemes0.21% of the company1,63,428 sharesholds 3.64% after20 May 2021 · filed under the 2% rule
Feb 2019
- SoldSBI Mutuakl Fund under its various schemes0.66% of the company5,20,179 sharesholds 5.74% after22 Feb 2019 · filed under the 2% rule
May 2017
- AcquiredSBI Funds Management Private Ltd8.10% of the company62,62,000 sharesholds 8.10% after18 May 2017 · filed under the 5% rule
- SoldSambhav Properties LLP9.18% of the company71,00,000 sharesholds 0.84% after18 May 2017 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Gufic Biosciences bulk deals
None in the last 12 months, since 29 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 30 Nov 20231 firm · ₹19 Cr bought · ₹19 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 5,87,787 at ₹329.69Sold 5,87,787 at ₹329.720.59% of the companyNet nil₹19 Cr bought
Thursday 12 Aug 20211 firm · ₹10 Cr bought · ₹0 soldNet bought ₹10 Cr
- BoughtFINANCIAL INVESTORS TRUST A/C GRANDEUR PEAK GLOBAL OPPORTUNITIES FUNDBought 5,00,000 at ₹205.890.52% of the company₹10 Cr
Wednesday 12 May 20211 firm · ₹8.75 Cr bought · ₹8.74 Cr soldNet bought ₹55,215
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,60,125 at ₹190.06Sold 4,60,125 at ₹189.940.59% of the companyNet nil₹8.75 Cr bought
Thursday 18 May 20175 firms · ₹58 Cr bought · ₹65 Cr soldNet sold ₹7.38 Cr
- SoldSAMBHAV PROPERTIES LLPSold 71,00,000 at ₹60.149.18% of the company₹43 Cr
- BoughtSBI MUTUAL FUNDBought 58,70,000 at ₹60.107.59% of the company₹35 Cr
- Both waysPARTH INFIN BROKERS PVT. LTD.Bought 13,91,309 at ₹72.67Sold 13,66,309 at ₹73.721.80% of the companyNet +25,000 shares₹10 Cr bought
- Both waysPARTH INFIN BROKERS PVT LTDBought 6,70,572 at ₹76.54Sold 6,70,572 at ₹76.570.87% of the companyNet nil₹5.13 Cr bought
- Both waysGKN SECURITIESBought 9,67,824 at ₹73.43Sold 9,67,824 at ₹73.421.25% of the companyNet nil₹7.11 Cr bought
Wednesday 31 Aug 20051 firm · ₹0 bought · ₹1.74 Cr soldNet sold ₹1.74 Cr
- SoldDHYUTI NIRMAL PATELSold 5,75,000 at ₹30.34₹1.74 Cr
Friday 26 Aug 20051 firm · ₹1.35 Cr bought · ₹1.30 Cr soldNet bought ₹0.06 Cr
- Both waysCHETNA VIJAY RATHOREBought 4,33,600 at ₹31.24Sold 4,15,694 at ₹31.22Net +17,906 shares₹1.35 Cr bought
Monday 1 Aug 20051 firm · ₹1.76 Cr bought · ₹1.81 Cr soldNet sold ₹0.04 Cr
- Both waysCHETNA VIJAY RATHOREBought 4,58,411 at ₹38.41Sold 4,68,905 at ₹38.50Net −10,494 shares₹1.76 Cr bought
Friday 22 Jul 20051 firm · ₹0.87 Cr bought · ₹0.91 Cr soldNet sold ₹0.04 Cr
- Both waysMS CHETNA VIJAY RATHOREBought 2,48,701 at ₹34.95Sold 2,59,501 at ₹34.95Net −10,800 shares₹0.87 Cr bought
Thursday 21 Jul 20051 firm · ₹2.35 Cr bought · ₹2.87 Cr soldNet sold ₹0.52 Cr
- Both waysCHETNA VIJAY RATHOREBought 6,86,115 at ₹34.20Sold 8,36,371 at ₹34.32Net −1,50,256 shares₹2.35 Cr bought
Wednesday 20 Jul 20052 firms · ₹1.68 Cr bought · ₹2.26 Cr soldNet sold ₹0.58 Cr
- SoldGUFIC PRIVATE LTDSold 4,00,000 at ₹26.55₹1.06 Cr
- Both waysCHETNA VIJAY RATHOREBought 6,06,641 at ₹27.74Sold 4,31,641 at ₹27.75Net +1,75,000 shares₹1.68 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 29 deals on record from 4 Jan 2004.